PolyPid

PolyPid R&D per Employee

The R&D Spending per Employee of PolyPid (PYPD) as of Oct 11, 2026 is 403,508.47 USD. In the previous year, R&D Spending per Employee was 386,627.12 USD — a change of 4.37% (higher).

R&D per Employee

403,508.47USD

YoY

4.37%

Last updated:

R&D Spending per Employee of PolyPid is 2025 403,508.47 USD. R&D Spending per Employee of PolyPid was 2024 386,627.12 USD. It decreases by 4.37% higher compared to the previous year.

The PolyPid R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
212,711.86 USD
Jan 1, 2019
238,694.92 USD
Jan 1, 2020
287,355.93 USD
Jan 1, 2021
515,644.07 USD
Jan 1, 2022
474,406.78 USD
Jan 1, 2023
273,694.92 USD
Jan 1, 2024
386,627.12 USD
Jan 1, 2025
403,508.47 USD
The PolyPid R&D per Employee history
YEARR&D per EmployeeYoY
403,508.47USD+4.37%
386,627.12USD+41.26%
273,694.92USD-42.31%
474,406.78USD-8.00%
515,644.07USD+79.44%
287,355.93USD+20.39%
238,694.92USD+12.22%
212,711.86USD+28.90%
165,016.95USD+26.31%
130,644.07USD+36.81%
95,491.53USD—
Access this data via the Eulerpool API

PolyPid Stock analysis

What does PolyPid do? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolyPid stock

R&D Spending per Employee of PolyPid is 403,508.47 USD in 2025.

R&D Spending per Employee of PolyPid changed from 386,627.12 USD to 403,508.47 USD, representing a 4.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee PolyPid since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's PolyPid historically and in real time.

Access this data via the Eulerpool API

Workforce — PolyPid

All Key Metrics — PolyPid